Viewing Study NCT07211659


Ignite Creation Date: 2025-12-24 @ 2:49 PM
Ignite Modification Date: 2025-12-25 @ 4:55 PM
Study NCT ID: NCT07211659
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-10-08
First Post: 2025-10-01
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Trial of THEO-260 (Administered Via Intraperitoneal Route) in Ovarian Cancer Patients
Sponsor: Theolytics Limited
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Ovarian Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Ovarian cancer View
None Oncolytic virus View
None Intraperitoneal administration View
None Dose escalation View